Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide | HCID 15908 | — |
| Reactant | HOAt | HCID 181649 | — |
| Reactant | HCID 69652404 | HCID 69652404 | — |
| Catalyst | 4-(Dimethylamino)pyridine | HCID 14284 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 69652414 | HCID 69652414 | 50% |
Reaction Steps
Add HOAt (30 mg, 0.22 mmol), EDCI (41 mg, 0.22 mmol), Et3N (0.075 mL, 0.54 mmol), and DMAP (5 mg, cat.) to a solution of 5-(9-chloro-3-methyl-4-oxo-5H-isoxazolo[4,3-c]quinolin-5-yl)-piperidine-1,3-dicarboxylic acid 1-tert-butyl ester (83 mg, 0.18 mmol) in DMF (5 mL). Stir overnight at room temperature and concentrate to dryness. Dissolve in 20% iPrOH/CHCl3. Wash 2× sat. aq NaHCO3, wash 2× with brine, dry over Na2SO4, filter, and concentrate to dryness. Purify by radial chromatography using a MeOH/CHCl3 gradient as eluant and concentrate to dryness. Slurry the residue in ether/hexanes and concentrate to dryness to afford the title compound (44 mg, 50%) as a white foam as a mixture of cis isomers. MS(IS) 552.2 (M+); HPLC (100% EtOH 0.2% DMEA on a Chiralpak AD (0.46×25 cm) 1.0 mL/min flow; 20 μL Inj. Vol.; 225 nM) Rt=6.291 min (67.8%), 13.156 min (24.4%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07101891B2 |
|---|
| Source dataset | uspto-grants-2006_09 |
|---|
| ORD ID | ord-75bc0cb9f8a541e49e9f0e4d7dd1ea16 |
|---|
| Source note | uspto-grants-2006_09 |
|---|